STOCKHOLM--(BUSINESS WIRE)--The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation of treatment ...

HOUSTON--(BUSINESS WIRE)--Qbtech, the global leader in objective ADHD testing, today announced the launch of its new grant program, QbAccess. Created to make ADHD testing and care more accessible to ...

Qbtech, the global leader in objective ADHD testing, today announced its one millionth patient milestone, amassing one of the most extensive data sets of patients tested for ADHD. Adopted by more than ...

Qbtech’s computer-based diagnostic tool QbTest has been recommended by the UK’s National Institute for Clinical Excellence (NICE) to support the diagnosis of attention deficit hyperactivity disorder ...

Industry-leading ADHD Test is the First, and Only, Digital Technology for Assessing ADHD to Achieve Endorsement The National Institute for Clinical Excellence (NICE), a UK government-funded, ...

Today, Qbtech, the software provider of objective ADHD tests QbTest and QbCheck, announces an investment by specialist growth equity investor, Verdane. Qbtech is the market leader in objective ...

Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: ...

East Midlands Academic Health Science Network teamed up with Qbtech Ltd to introduce a computer-based test for attention deficit hyperactivity disorder, and won the 2018 HSJ Award for Innovation in ...

The U.K. National Institute for Health and Care Excellence endorsed the Qb Test by Qbtech AB of Stockholm to aid in diagnosis of attention deficit/hyperactivity disorder in those aged 6 to 17.